Cascade Technologies, Corp. operates as a development-stage medical imaging device company. The company develops optical diagnostic products that operate in conjunction with surgical and/or evaluation procedures in real time. Its spectral-optical-imaging technology might be used for early diagnoses of various diseases, such as Barrett’s esophagus, a condition caused by chronic acid reflux that can lead to esophageal cancer; lung cancer; and melanoma. The company was founded in 2004 and is based in Beverly Hills, California.